title: Characterisation of glomerular haemodynamic responses to SGLT2 inhibition in patients with type 1 diabetes and renal hyperfiltration.
authors.affiliation: Department of Medicine, Division of Nephrology, Toronto General Hospital, University of Toronto, 585 University Ave, 8N-845, Toronto, ON, Canada, M5G 2N2.
authors.forename: Marko
authors.initials: M
authors.lastname: Skrtić
authors.forename: Gary K
authors.initials: GK
authors.lastname: Yang
authors.forename: Bruce A
authors.initials: BA
authors.lastname: Perkins
authors.forename: Nima
authors.initials: N
authors.lastname: Soleymanlou
authors.forename: Yuliya
authors.initials: Y
authors.lastname: Lytvyn
authors.forename: Maximilian
authors.initials: M
authors.lastname: von Eynatten
authors.forename: Hans J
authors.initials: HJ
authors.lastname: Woerle
authors.forename: Odd Erik
authors.initials: OE
authors.lastname: Johansen
authors.forename: Uli C
authors.initials: UC
authors.lastname: Broedl
authors.forename: Thomas
authors.initials: T
authors.lastname: Hach
authors.forename: Melvin
authors.initials: M
authors.lastname: Silverman
authors.forename: David Z I
authors.initials: DZ
authors.lastname: Cherney
mesh_terms: D001559:Benzhydryl Compounds / Q000494:pharmacology / Q000627:therapeutic use*; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy* / Q000503:physiopathology; D005960:Glucosides / Q000494:pharmacology / Q000627:therapeutic use*; D006439:Hemodynamics / Q000187:drug effects / Q000502:physiology; D006801:Humans; D007004:Hypoglycemic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D007678:Kidney Glomerulus / Q000187:drug effects* / Q000503:physiopathology; D051297:Sodium-Glucose Transporter 2; D000077203:Sodium-Glucose Transporter 2 Inhibitors
chemical_list: D001559:Benzhydryl Compounds; D005960:Glucosides; D007004:Hypoglycemic Agents; C089180:SLC5A2 protein, human; D051297:Sodium-Glucose Transporter 2; D000077203:Sodium-Glucose Transporter 2 Inhibitors; C570240:empagliflozin